Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
39 Cards in this Set
- Front
- Back
Most OCPs contain synthetic estrogen in the form of?
|
ethinyl-estradiol
|
|
Most OCPs contain which progestins? (4 most common)
|
norethindrone, levonorgestrel, and the newer desogestrel and norgestimate
|
|
T/F - Progestin is most important for contraception
|
True
|
|
T/F - Both estrogen and progestin (a balance between the two) are involved in cycle control.
|
True
|
|
Estrogen doses range between?
|
Dosage ranges 50mcg to 20mcg
98% of products contain 35 mcgs of estrogen or less |
|
Indications for progestin only formulations
|
Postpartum < 6 weeks
Lactating patients (may change to COC when supplemental feedings are introduced) |
|
Proposed advantages of variable regimens
|
more physiologic hormone levels (phasic regimens do not approximate “normal” cycle patterns),
improved cycle control with lower total hormone doses reduced side effects (possibly due to lower hormone doses) |
|
Describe monophasic hormone regimen
|
Estrogen & Progesterone levels constant.
Most common. |
|
Describe bi-phasic hormone regimen
|
Estrogen constant for 21 days;
progestin decreases late in cycle. |
|
Describe tri-phasic hormone regimen
|
Progestin (and/or estrogen) varies in three phase cycle
|
|
T/F - Oral contraceptives can be used safely by women until menopause.
|
True.
The FDA removed the age restriction for COCs in non-smokers. |
|
T/F - The risk for thromboembolism increases over the age of 35 for women who are obese and who smoke.
|
True
|
|
The lowest dose of estrogen is recommended. What is recommended dose?
|
20 ug
|
|
T/F - Progestin only pills have higher efficacy rates?
|
F
|
|
Contraindications to COCs
|
Pregnancy
Malignancy (breast, endometrial, hepatic) Thromboembolic disorders Major surgery with expected prolonged immobilization Smokers > 35 Heavy smokers of any age CAD Uncontrolled hypertension Undiagnosed vaginal bleeding Migraine h/a with aura |
|
What typically guids the selection of one COC prep over another?
|
Differences in the side effect profiles of the progestin component is determining factor.
|
|
Describe early BTB and the tx
|
Early BTB (occurs in the first 3-4 cycles of use) generally requires no treatment.
|
|
Describe late BTB and the tx
|
BTB occurring later, after 3-4 cycles of use or after many cycles of use may require intervention. The most common cause, missed pills, should be ruled out before making changes to formulations.
|
|
Causes of late BTB
|
Missed pills* - MC
Smoking Infection Formulation adjustment needed Drug interactions |
|
Estrogen related side effects such as nausea, breast tenderness may be minimized by _________?
|
selection of low dose formulations.
Or, use of progestin only products |
|
Breakthrough bleeding or spotting may be minimized by _____?
|
altering the ratio of estrogen to progestin.
and/or verify compliance |
|
Progestin related side effects such as acne and hirsutism can be improved by _______?
|
May improve on newer progestins
Switching to alternative progestin |
|
What can you do to prevent risk of thrombosis?
|
Use lowest possible estrogen dose
No increased risk of thrombosis from current low dose estrogens is seen. |
|
What can you do to prevent risk of dyslipidemia?
|
Use low dose progestin formulations
Consider newer progestins |
|
Mechanisms leading to drug interactions with OC include _____ and _____?
|
CYP3A4 induction and interference with intestinal flora.
|
|
T/F - If you take an OC and Antibiotics (broad spectrum) penicillins, tetracycline or Griseofulvin, you need to use back up contraception.
|
True
|
|
T/F - A person taking OCs and Acitretin (soratane) should use a back-up method of contraception.
|
True
|
|
Anticonvulsants such as phenytoin, carbamazepine, phoneobarbital and primidone reduce the effectiveness of OCPs by what mechanism?
|
Cytochrome P450 interaction (CYP3A4 induction)
|
|
Implanon
Drug and MOA |
etonogestrel (3-keto-desogestrel), the active metabolite of desogestrel (newer progestin)
Effective for 3 years Inhibits ovulation during the entire treatment period |
|
NuvaRing
Drug and MOA |
Releases 15 ug of ethinyl estradiol and 120 ug of etonogestrel (progestin, metabolite of desogrestrel) daily
|
|
Mirena
Drug and MOA |
Releases 20 ug of levonorgestrel (progestin) per 24 hrs
Duration: 5 years |
|
OrthoEvra
Drug and MOA |
Delivers continuous systemic doses of hormones
150 µg norelgestromin (NGMN)(metabolite of norgestimate) 20 µg ethinyl estradiol (EE) |
|
OrthoEvra causes a significantly increased risk of ___?
|
thromboembolism
|
|
Estimated Effectiveness of E.C.
|
75%
|
|
Options for E.C.
|
Emergency contraceptive pills
Progestin only pill administration Danazol administration Post-coital IUD insertion High dose estrogen administration Mifepristone (RU 486) Early pregnancy identification and early abortion |
|
What is the Yuzpe Method for E.C.?
|
Using combined oral contraceptives with a total dose of estrogen (ethinyl estradiol) of 200 mcg and progestin (norgestrel) of 2 mg
The first dose is taken as soon as possible after unprotected intercourse (up to 72 hours later) and the second dose is taken 12 hours after the first |
|
Meclizine or Diphenhydramine may be given with COCs as E.C. to prevent ___?
|
n/v
|
|
Synthetic androgen that can be used as E.C.?
|
Danazol
mixed results but consider for women with contraindications to estrogens. |
|
Potent anti-progesterone that can be used as E.C.?
|
Mifepristone
Endometrium b/c unsuitable for implantation. |